To view or add a comment, sign in Sustainable obesity care is about more than prescriptions
A secondary endpoint involved the number of satisfying sexual events occurring within 16 hours of taking the study drug and reported within 72 hours
SGLT-2 inhibitors and GLP-1RA should, therefore, be considered evidence-based treatments for patients with type 2 diabetes after metformin
However, since Saxenda (liraglutide) became the first GLP-1 approved for weight loss in 2014, additional options like Wegovy (semaglutide) and Zepbound (tirzepatide) have also been approved for weight management
Game Changers The game that invites you to test your knowledge of GLP-1 RAs It's time to test your knowledge about GLP-1 RAs and their benefits as they relate to type 2 diabetes
Researchers are currently investigating whether using GLP-1s leads to a higher proportion of lean mass loss, but the available evidence suggests that people who lose weight while using GLP-1s can still maintain or even improve their muscle function